RAIDD, a novel death adaptor molecule
US6495322B1 · kind B1 · utility
3Cited by
3References
93Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 7, 2000 |
| Grant date | Dec 17, 2002 |
| Priority date | — |
| Expiry date | Apr 7, 2020 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2510/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a novel molecule involved in the process of apoptosis. In particular, isolated nucleic acid molecules are provided encoding the human RAIDD protein and splice variants thereof—referred to as RAIDD-SV1 and RAIDD-SV2. RAIDD polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of RAIDD activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.